•   Asia Pacific
  • Services
  • Sustainability
  • Search

Press

New Research Identifies Potential Biomarkers of Gut Health in Broilers

New Research Identifies Potential Biomarkers of Gut Health in Broilers
Research demonstrates Novus International’s commitment to the understanding of basic physiological and metabolic processes in poultry

 ST. LOUIS (July 29, 2015)—Alternative grains, such as wheat, barley and rye which are high in non-starch polysaccharides (NSP), can have a substantial negative impact on monogastric digestion and animal performance. Chickens have little or no intrinsic enzymes capable of hydrolyzing these NSP, leading to restricted digestibility of feed ingredients and significant reductions in growth. Undigested feed ingredients in the gut provide nutrients for bacteria overgrowth in the hind gut, which can lead to dysbacteriosis. High NSP diets have also been associated with bacterial diseases that have major economic implications in broiler chickens.

In a recent research study entitled “Identification of potential biomarkers for gut barrier failure in broiler chickens,” published in Frontiers in Veterinary Sciences, Novus International, Inc., and University of Arkansas researchers used coccidiosis over-vaccination to trigger a gut health challenge in broiler chickens fed a wheat–barley–rye diet. The overall growth performance and feed efficiency were severely reduced by this gut barrier failure (GBF) model. The results of this study are in agreement with previous studies that concluded high NSP diets compromised growth performance in chickens.

The purpose of the study was not to determine the individual effects of diet ingredients or coccidia challenge, but rather to determine potential biomarkers that may be used to define GBF in future studies. Biomarkers could be useful to monitor poultry health and understand disease mechanisms.

“This research demonstrates Novus’s commitment to the understanding of basic physiological and metabolic processes in poultry,” commented Jeffery Escobar, Executive Manager of Physiology Research at Novus. “The results of this study will allow scientists at Novus, academia, and other poultry researchers to perform better evaluations of gut health parameters and enhance the ability to test solutions, which can translate into safer poultry products for human consumption.”

To review the full study, visit this link. To learn more about Novus International, visit www.novusint.com.

###

About Novus International, Inc.

Novus International, Inc. is headquartered in metropolitan St. Louis, Missouri, U.S.A. and serves customers in over 100 countries around the world. A global leader in developing animal health and nutrition solutions, Novus International’s products include ALIMET® and MHA® feed supplements, ACTIVATE® nutritional feed acid, ACIDOMIX® preservative premixture, CIBENZA® enzyme feed additive, MINTREX® chelated trace minerals, SANTOQUIN® feed preservative, AGRADO® feed antioxidant and many other specialty ingredients. Stratum Nutrition, a division of Novus Nutrition Brands, LLC, focuses on human nutrition through specialty and functional ingredients for manufacturers of foods, beverages and dietary supplements (www.stratumnutrition.com).

Novus is privately owned by Mitsui & Co. (U.S.A.), Inc. and Nippon Soda Co., Ltd. For more information, visit www.novusint.com. ©2015 Novus International, Inc. All rights reserved.